Deflazacort
PTCEMF-GD-004
Phase 3 small_molecule terminated
Quick answer
Deflazacort for Limb-Girdle Muscular Dystrophy is a Phase 3 program (small_molecule) at PTC THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PTC THERAPEUTICS, INC.
- Indication
- Limb-Girdle Muscular Dystrophy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated